person · Reporting owner
Veillon-Berteloot Chantal
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | EVP & CHRO | September 01, 2026 | September 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date September 01, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,772 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Tax withholding · Disposed 1,455 · Balance 20,772 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 4, 2026 11:56 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,455 | $16.62 | $24,182.10 |
DisclosureSEC source: 0001990905-26-000004 · wk-form4_1788522975.xml · nonDerivative · entry 1 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,772 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:15 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantRestricted Stock Units · Derivative | 41,783 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001990905-26-000002 · wk-form4_1773350115.xml · derivative · entry 2 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,783 Underlying: Common Stock · 41,783 shares Expires not disclosed F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:15 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 5,420 | $9.61 | $52,086.20 |
DisclosureSEC source: 0001990905-26-000002 · wk-form4_1773350115.xml · nonDerivative · entry 1 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,227 Read SEC document |
| September 01, 2025 Filed Sep 2, 2025 20:33 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,412 | $15.13 | $21,363.56 |
DisclosureSEC source: 0000917520-25-000083 · wk-form4_1756845215.xml · nonDerivative · entry 2 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,647 Read SEC document |
| September 01, 2025 Filed Sep 2, 2025 20:33 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 2,139 | $15.13 | $32,363.07 |
DisclosureSEC source: 0000917520-25-000083 · wk-form4_1756845215.xml · nonDerivative · entry 1 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,059 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon- Qualified Stock Option (right to buy) · Derivative | 15,549 | $0.00 Strike: $23.95 | $0.00 |
DisclosureSEC source: 0000917520-25-000025 · wk-form4_1741897599.xml · derivative · entry 3 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,549 Underlying: Non-Qualified Stock Option (right to buy) · 15,549 shares Expires 2033-03-11 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2025. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 7,343 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-25-000025 · wk-form4_1741897599.xml · nonDerivative · entry 2 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,198 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 524 | $23.95 | $12,549.80 |
DisclosureSEC source: 0000917520-25-000025 · wk-form4_1741897599.xml · nonDerivative · entry 1 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,855 Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 20:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,412 | $20.34 | $28,720.08 |
DisclosureSEC source: 0000917520-24-000096 · wk-form4_1725394710.xml · nonDerivative · entry 1 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,379 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon- Qualified Stock Option (right to buy) · Derivative | 8,027 | $0.00 Strike: $36.22 | $0.00 |
DisclosureSEC source: 0000917520-24-000033 · wk-form4_1710361643.xml · derivative · entry 3 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,027 Underlying: Common Stock · 8,027 shares Expires 2032-03-11 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2024. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 8,283 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000033 · wk-form4_1710361643.xml · nonDerivative · entry 2 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,791 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,475 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000033 · wk-form4_1710361643.xml · nonDerivative · entry 1 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,508 Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 9,355 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-048135 · doc4.xml · nonDerivative · entry 2 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,033 Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 4,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-048135 · doc4.xml · nonDerivative · entry 1 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,678 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.